Accessibility helpSkip to navigationSkip to contentSkip to footer
Open side navigation menuOpen search bar
myFT

Graphics

Beta

Explore FT stories through charts and graphics

Search graphics

Our suggestions

Recent graphics 1 - 12 of 489

China's slow vaccine rollout. Chart showing cumulative doses administered per 100 residents. Israel leads the world with 86 doses per 100 people as of Feb 24. China has only managed 2.9 doses per 100 people as of Feb 9
Covid-19 vaccinesFebruary 28, 2021
Topic: Coronavirus treatment, Pharmaceuticals sector, Medical science
Organisation: Sinovac Biotech Ltd, CanSino Biologics, Sinopharm Group Co Ltd
Location: China
Some EU countries are facing a squeeze on vaccine supply. Marimekko chart showing per cent of distributed doses administered and total doses distributed
Covid-19 vaccinesFebruary 25, 2021
Topic: Pharmaceuticals sector
Organisation: European Union
Location: Sweden, France, Europe, Denmark, Germany
Line chart of Rebased to Aug 2020 showing Vaccine makers' share prices
Covid-19 vaccinesFebruary 23, 2021
Topic: European companies, Pharmaceuticals sector
Organisation: CureVac GmbH
Bar chart of Covid-19 shots under contract (doses bn) showing Vaccine makers race to supply the world
Covid-19 vaccinesFebruary 23, 2021
Topic: European companies, Pharmaceuticals sector
Organisation: CureVac GmbH
Chart showing that Scottish data shows a single dose of Covid-19 vaccines offers very strong protection against hospitalisation, including among the elderly
Covid-19 vaccinesFebruary 23, 2021
Topic: UK politics & policy, Medical science, Pharmaceuticals sector
Organisation: University of Edinburgh, BioNTech, Pfizer Inc, AstraZeneca PLC
Chart showing that English data shows strong vaccine efficacy among healthcare workers aged under 65, including after a single dose
Covid-19 vaccinesFebruary 23, 2021
Topic: UK politics & policy, Medical science, Pharmaceuticals sector
Organisation: University of Edinburgh, BioNTech, Pfizer Inc, AstraZeneca PLC
Chart showing that English data shows BioNTech/Pfizer vaccine offers good protection against infection among over-80s, especially after a second dose
Covid-19 vaccinesFebruary 23, 2021
Topic: UK politics & policy, Medical science, Pharmaceuticals sector
Organisation: University of Edinburgh, BioNTech, Pfizer Inc, AstraZeneca PLC
Map of Germany
Covid-19 vaccinesFebruary 22, 2021
Topic: Coronavirus pandemic, European companies, Health, Pharmaceuticals sector
Organisation: BioNTech, Pfizer Inc
Person: Ugur Sahin
Global production of the Russian Sputnik V vaccine
Covid-19 vaccinesFebruary 18, 2021
Topic: Pharmaceuticals sector
Organisation: Russian Direct Investment Fund
Location: Russia
Global production of the Russian Sputnik V vaccine
Covid-19 vaccinesFebruary 18, 2021
Topic: Pharmaceuticals sector
Organisation: Russian Direct Investment Fund
Location: Russia
Covax’s vaccine portfolio. Waterfall chart showing Covax available supply (million doses, 2021 and 2022, as of Jan 20 2021). Secured volumes from legally-binding agreements from BioNTech/Pfizer Oxford/AstraZeneca SII(Novavax) SII(Oxford/AstraZeneca) totalling 1.31 billion Secured volumes from non-binding agreements from Sanofi/GSK Johnson & Johnson totalling 700 million Near-term agreements on volumes under active negotiation from Candidate A, B and C totalling 780 million Making 2.79bn billion doses in total
Covid-19 vaccinesFebruary 12, 2021
Topic: Medical science, Pharmaceuticals sector
Advanced economies are well ahead on vaccinations. Scatter graph showing Progress on vaccinations vs. death toll, circle size represents population. Israel is way out in front with more than 65 doses per 100 people. With the UK and US well ahead of all emerging and developing economies bar UAE and Seychelles
Covid-19 vaccinesFebruary 12, 2021
Topic: Medical science, Pharmaceuticals sector
Load more
Top